Feb. 28, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF) is pleased to announce that it has closed today its previously announced "bought deal" short form prospectus offering of common shares ("Common Shares"), including the exercise in full of the over-allotment option (the "Offering").
Read more
Khiron Announces Closing of $28.84 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
